Imagine a seasonal jab of antibodies that could neutralize the HIV virus.
Researchers have discovered a potential way to "tune up" the immune system's ability to kill cancer cells.
This process of viral adaptation is constantly occurring, and some adaptations persist even after sequential transmissions to new individuals.
Researchers said that measuring EoP blood levels to monitor disease activity has the potential to reduce discomfort, costs and side effects for patients.
The amount of NET complexes in the lungs of patients in the study was directly related to the severity of their COPD and the risk of exacerbations.
Alex Gorsky discussed everything from developing new drugs to establishing an appropriate pricing system for these medications.
Computing giant IBM has unveiled a new macromolecule-like “molecular Velcro” to kill viruses like Ebola, herpes, dengue and influenza, according to the company.
Anacor's stock soared more than 53 percent in Monday premarket trading.
The acquisition is expected to close by the end of the third quarter.
Researchers have found that patients with celiac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine.
Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that's a good idea.
Red wine lovers have a new reason to celebrate.
The Philadelphia randomized control study placed 290 11- and 12-year-olds with a history of violence into four groups.
The company's announcement has limited immediate impact.